Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to ...

Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of ...

Gig roles are emerging in India's corporate sector, with IT, pharmaceuticals, and energy firms hiring senior executives on ...

Genialis, the RNA biomarker company, today announced the commercial availability of Genialistm krasID, the first biomarker algorithm that can predict patient response and clinical benefit to KRAS ...

The World Mental Health Coalition's major conference this Friday at the Press Club will be like no other. The special conference website with the latest information is DANGEROUSCASE.org.   After the ...

Q2 2024 Earnings Call Transcript September 24, 2024 Operator: Good morning, and welcome to the Altamira Therapeutics First ...

Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to ...

Medigene continually extends and strengthens its patent portfolio with new technologies and expands existing patents into additional jurisdictions. The Company maintains 29 different patent families ...

Silexion Therapeutics sees surge in trading volume after revealing new findings from a Phase 2 trial of LODER in pancreatic ...

Altamira’s Senior Management will hold an investor call today, Tuesday, September 24, 2024, at 8:30 a.m. EDT its business update and first half 2024 results. Founder, Chairman, and CEO Thomas Meyer ...

HOOKIPA is very pleased to present a comprehensive preclinical proof-of-concept dataset related to HB-700, for the potential treatment of KRAS mutated cancers. KRAS mutations are most frequently found ...